Abstract:Background: Lung cancer is the most common primary malignant tumor of the lung, and as one of the malignant tumors that pose the greatest threat to the health of the population, the incidence rate has remained high in recent years. Previous studies have shown that KLRB1 is transcriptionally repressed in lung adenocarcinoma and correlates with lung adenocarcinoma prognosis. The objective of this study is to investigate the intrinsic mechanisms by which KLRB1 affects the malignant phenotypes of lung adenocarcinoma such as immune infiltration, proliferation, growth and metastasis. Methods: We assessed the expression levels of KLRB1 in publicly available databases and investigated its associations with clinical and pathological variables. Enrichment analysis was subsequently conducted to investigate possible signaling pathways and their associated biological functions. Statistical analysis, including Spearman correlation and the application of multigene prediction models, was utilized to assess the relationship between the expression of KLRB1 and the infiltration of immune cells. The diagnostic and prognostic value of KLRB1 was evaluated using Kaplan-Meier survival curves, diagnostic receptor operating characteristic (ROC) curves, histogram models, and Cox regression analysis. Specimens from lung adenocarcinoma (LUAD) patients were collected, the expression level of KLRB1 was detected by protein blotting analysis, and the expression level of KLRB1 was detected at the mRNA level by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). Small interfering RNA (siRNA) was used to silence gene expression, and Transwell, Cell Counting Kit-8 (CCK-8) and colony formation assays were subsequently performed to analyze the effects of KLRB1 on LUAD cell migration, invasion and proliferation. Results: KLRB1 expression was lower in lung cancer tissue than in surrounding healthy tissue. Genes differentially expressed in the low and high KLRB1 expression groups were found to be significantly enriched in pathways related to immunity. KLRB1 exerted an impact on the MAPK/ERK signaling pathway, thereby modulating the growth and proliferation of LUAD cells. KLRB1 expression is linked to prognosis, immune infiltration, and cell migration and proliferation in LUAD. Conclusions: The evidence revealed a correlation between KLRB1 and both prognosis and immune infiltration in LUAD patients.

[Effect of transfection of LKB1 on biological behavior of human lung adenocarcinoma cells].

[Effect of Small Interfering RNA-induced LKB1 Gene Silencing on the Biological Behavior of Lung Carcinoma Cells].

Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway

Effect of Inhibitor Κb Transfection on Tumorigenesis of Human Lung Cancer Cell Line H460

Cytoplasmic Liver Kinase B1 Promotes the Growth of Human Lung Adenocarcinoma by Enhancing Autophagy.

Overexpression of the LKB1 Gene Inhibits Lung Carcinoma Cell Proliferation Partly Through Degradation of C-Myc Protein.

Suppression of Lung Cancer Cell Invasion by LKB1 is Due to the Downregulation of Tissue Factor and Vascular Endothelial Growth Factor, Partly Dependent on SP1

Effect of integrin β1 up-regulation on the migration and adhesion capacity of lung cancer cell

[Function and Prognostic Value of Tumor Suppressor Gene LKB1 in Human Breast Carcinoma].

Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells Via AKT Pathway.

Expression Profiling of Ubiquitin-Related Genes in LKB1 Mutant Lung Adenocarcinoma.

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway

[Effects of Hnrnp B1 on DNA-PK Activity, Cell Cycle and Apoptosis in Human Lung Adenocarcinoma Cell Line A549].

Effects of TRB3 on Biological Behavior of Human Lung Adenocarcinoma Cells

Influence of Specific Down-Regulation of LKB1 Expression on Invasion and Migration of Hepatoma Cells

Expression and transcriptional profiling of the LKB1 tumor suppressor in cervical cancer cells.

Glycogen Synthase Kinase 3beta Induces Cell Cycle Arrest in a Cyclin D1-dependent Manner in Human Lung Adenocarcinoma Cell Line A549.

[The Effect of PTC1 Transfection on the Growth and Apoptosis of Human Pulmonary Adenocarcinoma Cell A549].

LKB1 suppresses the progression of thymic carcinoma via epithelial-mesenchymal transition

Experimental Study on Inhibition Effects of the XAF1 Gene Against Lung Cancer Cell Proliferation.

Integrative Genomic Analysis Reveals a High Frequency of LKB1 Genetic Alteration in Chinese Lung Adenocarcinomas.